LeMaitre Vascular, Inc. (LMAT)
Nasdaq: LMAT · Surgical & Medical Instruments & Apparatus · Burlington, MA · filing with the SEC since 2002
Grade6.9
◀ Past 7.6● Present 7.2▶ Future 6.0
Who runs LeMaitre Vascular, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Lemaitre George W
Chairman and CEO. First filing Oct 2006, latest Sep 8, 2026, 71 filings in all.
Officers reporting now
5
of 10 people with a filing in the last fifteen months
Directors reporting now
5
14 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Lemaitre George W | Chairman and CEO | Oct 2006 | Sep 8, 2026 | 4 · $27.1M |
| Roberts David B | President and Director | Oct 2006 | Sep 8, 2026 | 2 · $1.3M |
| Leblanc Dorian Paul | Chief Financial Officer | Mar 2025 | Sep 8, 2026 | none |
| Pellegrino Joseph P Jr | Chief Financial Officer | Oct 2006 | Sep 8, 2026 | none |
| Kamke Trent G | Senior V. P., Operations | Oct 2006 | Sep 8, 2026 | 3 · $700,000 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Jasinski Lawrence J | director | Oct 2006 | Sep 8, 2026 | 1 · $400,000 |
| O'Connor John James | director | Sep 2008 | Sep 8, 2026 | none |
| Roush John A | director | Apr 2014 | Sep 8, 2026 | none |
| Shadan Martha | director | Sep 2022 | Sep 8, 2026 | none |
| Ross Bridget A | director | May 2020 | May 11, 2026 | 1 · $600,000 |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.